Preclinical Validation of First in Man Endovascular Brain Machine Interface Device [ 2018 - 2020 ]

Research Grant

Researchers: Dr Thomas Oxley (Principal investigator) ,  Dr Nicholas Opie

Brief description The stentrode technology has been given significant public attention, following publication in the fourth highest impact factor journal 'Nature Biotechnology' and a public statement of endorsement by the President of the United States in 2016. The program now seeks to conduct a preclinical validation program to satisfy the FDA in its requirements to provide Investigational Device Exemption (IDE).

Funding Amount $AUD 882,180.00

Funding Scheme Development Grants

Notes Development Grant